Home TScan Therapeutics

TScan Therapeutics

In operation
Seasoned Equity Offering
Developer of New Anti-Tumor Drugs
Basic
Enterprise Profile

Basic Information

TScan Therapeutics Focuses on Developing Immuno-Oncology Therapies to Enhance the Effectiveness of New Treatments That Don't Work for Patients by Reducing Drug Side Effects. By Discovering New Cancer Targets, TScan Develops Safe and Effective T-Cell Therapies for Patients to Improve Their Lives.
TScan Therapeutics, Inc.
Massachusetts,United States of America
51~100 people
January 01, 2018
info@tscan.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Targeted Technology Immunological Techniques Cell Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy